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Cytotoxic thymus-derived lymphocytes (CTL) generated by exposure to cells 
modified with trinitrophenyl (TNP) groups, or by the process of virus infection, 
interact maximally with target cells which share both self (H-2K or H-2D) and 
nonself (TNP or virus) determinants with the stimulator cell population (1-4). 
One explanation for this phenomenon is that the T-cell receptor(s) are specific 
for an "altered-self' component, perhaps a  complex of TNP (or virus) and H-2 
molecules (1, 5, 6). 
Analysis of the virus-immune CTL response of H-2K mutant mice indicates 
that there is no cross-reactivity between the wild-type and two H-2K mutant 
haplotypes  (1,  7,  8).  Thus,  it  may  be  that  the  H-2K  component which  is 
recognized by virus-immune CTL may be quite limited in extent, perhaps being 
modified by mutations which affect only a few amino acid substitutions (1). In 
contrast, the wild-type and H-2K mutant strains exhibit extensive cross-reactiv- 
ity in the TNP-immune CTL response (9). One interpretation of these contrast- 
ing results is that TNP and viral components may form altered-self  components 
by interaction with separate reactive sites on H-2 molecules. 
Thorough biochemical studies (10) on TNP-modified cells have shown that the 
treatment schedules (6,  11) utilized to prepare both stimulator and target cells 
result in stable substitution of all cell surface H-2 molecules. We thus asked 
whether prior substitution of the cell membrane with TNP would in any way 
inhibit the capacity of virus to induce specific cell surface modifications which 
are  recognized by  virus-immune CTL.  Are  reactive  sites  on  H-2  molecules 
shared between the two systems? 
Materials and Methods 
Viruses.  The  influenza type  A  viruses  PR8  [A/PR/8/34  (HON1)],  AA  [A/Ann Arbor/23/57 
(H2N2)],  and HK  [A/Hong Kong/8/68-X-31 (H3N2)] were supplied and grown as described (12). 
The WR strain of vaccinia virus was used throughout (13). 
Immunizations.  Influenza-immune T cells were obtained from the spleens of mice primed with 
AA, challenged 1 mo later with HK or PR8,  and killed after a  further 4 days (12).  For vaccinia 
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FIG.  1.  CTL  generated  by  immunization of CBA/J  (H-2k)mice  with  vaccinia virus  or 
influenza virus lyse virus-infected, but not TNP-modified,  H-2-matched target cells. The 
TNP assays were incubated for 6 h, the virus assays for 12 h. These assays are, at least for 
the influenza system,  approximately  equivalent,  since maximal antigenic expression on 
influenza-infected L  cells does not occur until at least 5-6 h  ai~r infection (see Fig.  3). 
Spontaneous 51Cr release for all target cells was less than 25%. 
immunization, 10  e mean tissue culture infective doses of vaccinia virus was inoculated intrave- 
nously into mice and their spleens were  harvested 6  days later  (13).  TNP-immune  CTL  were 
generated by culturing  normal spleen  cells for 5  days  in  vitro with  irradiated TNP-modified 
syngeneic spleen cells as described by Burakoff et al.  (11). 
Cytotoxicity Assay.  Cytotexicity  against 51Cr-labeled influenza- and vaccinia-infected L929 
fibroblasts  (C3H  L  cells,  H-2 k)  and  MC57G  sarcoma  cells  (C57BL/6,  H-2 ~)  was  measured  as 
outlined in detail elsewhere (12). For TNP modification, 1-2 x  107 cells were reacted with 150 ~1 of 
2.5 mM trinitrobenzene sulfonic acid in phosphate-buffered saline, pH 7.2,  for 10 rain at 37°C, 
washed,  and labeled with Na2 s~CrO~. Results are expressed as percent specific s]Cr release (12) 
and are the means of quadruplicate determinations. 
Results and Discussion 
The results in Fig.  1 and Table I demonstrate that TNP-modified L cells are 
lysed by TNP-immune  but not influenza-  or vaccinia-immune  H-2 compatible 
lymphocyte populations.  Target cells which were first modified with TNP and 
then  infected  with  influenza  virus  were  killed  by both  TNP-  and  influenza- 
immune CTL (Table I), but not by H-2 incompatible virus-immune effector cells. 
Furthermore,  competitive  inhibition  experiments  clearly  demonstrated  that 
anti-TNP and anti-influenza CTL were specific for the antigens used for sensiti- 
zation (Fig.  2). 
Therefore, saturation of the plasma membrane with TNP does not detectably 
inhibit the capacity of influenza virus to infect cells or to induce the expression 
of antigen(s) which are recognized by influenza-immune  CTL. These results do 
not simply reflect binding  of the influenza  virus inoculum to which the  cells BIDDISON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
T  cells Recognize Two Distinct Neoantigens on One Target Cell 
619 
% Specific ~Cr release* 
Mouse strain  Immune lympho-  L cells  (H-2  ~) 
cyte8* 
MC57G 
(H-2 b) 
Normal  TNP  TNP + HK  HK  HK 
CBA/J  (H.2  k)  TNP  16  84  100  19  1 
Influenza 1  0  1  41  52  0 
Influenza 2  0  2  76  66  0 
C57BL/6 (H.2 b)  Influenza 1  1  2  6  3  25 
Influenza 2  3  3  7  5  39 
* TNP-immune effector cells were obtained  from 5-day in vitro cultures  of CBA spleen cells and irradiated TNP- 
modified CBA spleen cells. Influenza-immune T cells were obtained  from mice primed i me previously with AA, 
challenged  with (group 1) AJPRS/1934 (HON1) or(group 2) HK and sampled 4 days later. Effector cell:target cell 
ratios were 20:1 for TNP-immune effectors and 40:1 for virus-immune effectors. 
Normal or TNP-modified  target cells were infected  with HK x  31 for 1 h at 37°C and then labeled  with Ne2 
SJCrO~. All  assays were then  incubated  for  12 h  at 37°C. The standard error of the mean of quadruplicate 
determinations was always less than 5% of the mean. 
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FIG.  2.  Competitive  inhibition  with  unlabeled  target  cells  indicates  that  different  T-cell 
populations  mediate  lysis directed against  viral and TNP  antigenic  determinants  expressed 
on  the  same  target  cells.  Effector  cell:  5~Cr-labeled  target  cell  ratios  were  10"1  for TNP- 
immune  effectors and  50:1 for HK-immune  effecters. All assays  were  incubated  for 12 h. 620  BIDDISON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIG.  3.  Normal or TNP-modified L cells were infected with influenza virus for 1 h at 37°C, 
washed once, dispensed into assay plates, and held at 37°C. Lymphocyte populations were 
added at times corresponding  to 1-6  h  after exposure  to the virus, and incubated for a 
further 6 h at 37°C. Effector cell:target  cell ratios were 35:1 for TNP-immune effectors and 
50:1 for normal and HK-immune effectors. 
were exposed,  since maximal antigenic  expression  at the plasma membrane  is 
only observed 5-6 h after exposure to virus (Fig. 3). Also, since influenza virus is 
a  potent inhibitor of host cell protein synthesis  (14), it is unlikely that any new 
H-2  antigen  is synthesized. 
Starzinski-Powitz et al.  (15) reported that cells first infected with lymphocytic 
choriomeningitis virus  (LCMV)  and then modified with TNP could be killed by 
both TNP- and LCMV-immune CTL.  However, LCMV might not be expected to 
"modify"  all  available  H-2  molecules  on these  cells,  since viral  antigen  is not 
expressed  at  a  particularly  high  concentration  on  the  cell  membrane  (P.  C. 
Doherty, unpublished observations). Also, Starzinski-Powitz et al. (15) observed 
that anti-vaccinia and anti-LCMV CTL lysed TNP-modified target cells almost 
as effectively as did anti-TNP CTL. Therefore, it could not be determined ifTNP BIDDISON  ET  AL.  BRIEF  DEFINITIVE  REPORT  621 
modification  of virus-infected cells altered the induction of virus-specific modifi- 
cations recognized by virus-immune CTL. 
In the present study, we have been unable to demonstrate any lysis of TNP- 
modified target  cells by  CTL from mice  immunized with  either  vaccinia or 
influenza virus. Target cells which were modified with TNP and then infected 
with influenza virus expressed distinct cell surface antigens recognized by TNP- 
and influenza-immune CTL. These results indicate that if altered-self antigens 
exist as a complex between nonself  and H-2 (16), there is probably more than one 
reactive  site  on  the  H-2  molecule.  If TNP-  and  virus-immune  CTL  do  not 
recognize TNP molecules or viral components but are reactive to specific confor- 
mational changes in H-2K or D  molecules induced by these agents, H-2K or D 
molecules must then be  able to simultaneously express  at least two distinct 
alterations. An alternative (17-19) is that individual T cells express two distinct 
receptors with specificity for self (H-2) and nonself (virus or TNP). 
Summary 
Cytotoxic thymus-derived lymphocytes generated after interaction with trini- 
trophenyl (TNP)-substituted or  virus-infected cells only lyse H-2  compatible 
target cells modified with the component used to immunize (TNP or virus). Prior 
saturation of TNP-reactive sites inhibits neither the infectivity of influenza A 
viruses,  nor the capacity of infected cells to develop antigenic changes recog- 
nized by influenza-immune T cells. The two antigens are distinct entities on the 
cell  membrane and do  not obviously compete to  form interactions with H-2 
molecules. 
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